Summary: The Phenistix screening test for phenylketonuria in newborn infants, when used routinely at the recommended age of 4 to 6 weeks, passes as normal a substantial proportion-perhaps between a quarter and a half-of children with the disease, who are then diagnosed only after brain damage has occurred. Screening procedures based on three other tests-namely, the paper chromatography test for o-hydroxyphenylacetic acid in urine, the Phenylketonuria is characterized by an excessive level of phenylalanine in the serum, appearing within a few days of birth, and usually resulting, if left untreated, in mental retardation. The disorder is due to a block in the metabolism of phenylalanine to tyrosine. The frequency of occurrence of the disease in the general population in Britain is probably of the order of 1 in 10,000 births, but the precise determination of the frequency is difficult because it depends on completeness of ascertainment of the disease in large populations, and indeed there is evidence that the frequency differs in different population subgroups (Carter and Woolf, 1961) . Because the condition is inherited as an autosomal recessive defect, the chance that another child will be affected in a family already having an affected child is one in four for each pregnancy.
Most (Gibbs and Woolf, 1959; Boyd, 1961; Farquhar, Kansas, and Tait, 1962) ; (2) the paper chromatography test for o-hydroxyphenylacetic acid in urine (Armstrong, Shaw, and Robinson, 1955 ; Berry, Umbarger, and Sutherland, 1964) ; (3) the Guthrie test for phenylalanine in blood (Guthrie, 1961) ; and (4) a modification (E. G. Hall, unpublished) of the Guthrie test for phenylalanine in urine (Guthrie and Tieckelmann, 1960) .
A number of other promising tests, which have not yet been used extensively in Britain, are referred to briefly at the end of the report.
Assessment of Screening Procedures
The purpose of all the screening procedures based on these tests is the same-namely, to enable abnormalities of phenylalanine metabolism to be detected at an early and presympto-matic stage. Experience suggests that in a patient in whom a screening test does not give a positive result the clinical diagnosis of phenylketonuria is likely to be delayed until the child is aged between 9 and 24 months, and possibly even longer. The Phenistix test will seldom be positive unless the phenylalanine level in the serum is above 15 mg./100 ml. (Armstrong and Low, 1957) , but it may be negative with considerably higher levels. During the first two to three weeks of life the test is often negative in an affected child because the concentration of phenylpyruvic acid in the urine is not sufficiently high (Armstrong, Centerwall, Horner, Low, and Weil, 1961; Berry et al., 1964 This test has been developed, both in the laboratory and in its practical application in a mass screening procedure, by Dr. L. I. Woolf, at the Radcliffe Infirmary, Oxford (Woolf, 1967) .
The test is made on filter paper which has been impregnated with urine and dried. The specimen is obtained by the mother, who is given a small supply of filter papers by the health visitor or welfare centre, with instructions on collecting the specimen, drying the paper, and writing identification particulars on it. The test paper or papers have in some areas been collected by a health visitor on a routine visit to the home and forwarded to the central processing laboratory ; in others they have been posted by the mother to the local health authority and thence to the laboratory. The test has usually been performed, for administrative convenience, at an age of about 10 to 14 days.
The test paper is first checked visually, and if necessary chemically, for the presence of urine. Part of the test paper is then mounted on a standard filter paper sheet and a onedimensional paper chromatographic test for urinary phenols (Armstrong, Shaw, and Wall, 1956 ) is run overnight. Ten test papers can be included on one standard sheet. If a suitable reagent is applied to the test paper the next day the appearance of a spot of distinctive colour and RF value indicates the presence of an abnormal concentration of o-hydroxyphenylacetic acid in the urine. The paper chromatography test, as used, detects concentrations of o-hydroxyphenylacetic acid down to about 0.2 mg./100 ml. of urine. Negative or very weak positive results for other, normal, urinary components would provide an indication that another specimen was required.
This test has been used routinely in Oxfordshire, Cardiff, Bletchley, and Chesham since July 1965. By July 1967 more than 21,000 infants had been tested; the numbers tested in the first year represented 96.2 % and those in the second year 98.7% of all live births in the area. The test was also introduced in Oxford City in January 1967. Apart from a few younger siblings of known patients with phenylketonuria, no child born in these areas during the period of use of this test is currently known to have the disease, whether routinely tested or not. The test has therefore not been used yet on a sufficient scale, or for long enough, in this area of low prevalence of the disease to assess reliably whether it misses patients with phenylketonuria, and, if so, how frequently.
With the urine chromatography test, about one nonphenylketonuric infant in 5,000 gave a weak positive reaction for o-hydroxyphenylacetic acid; in addition, eight infants per 1,000 showed tyrosyluria, necessitating examination of a second urine specimen for o-hydroxyphenylacetic acid.
The laboratory procedure outlined above also indicates the presence of abnormal concentrations of p-hydroxyphenyllactic acid in the urine (tyrosyluria and tyrosinosis) and of histidine in the urine (histidinaemia). Other portions of the same test paper may be used to test for conditions other than phenylketonuria, namely proteinuria, glucosuria, galactosaemia, cystinuria, and homocystinuria.
Guthrie Test on Blood
The practical application of this test in a screening procedure in Britain has been developed by Dr. J. S. Stevenson and Dr. J. Scott at Stobhill General Hospital, Glasgow. The test is made on filter paper which has been impregnated with several spots of blood obtained by heel-prick and dried. The specimen is obtained from infants delivered in hospital by the hospital medical or nursing staff; in the case of early discharges arrangements for testing have been made through the Public Health Department. The midwife, or exceptionally the general practitioner, obtains the specimen from infants delivered at home. In this country a single test has been performed at an age of 6 days or as soon as possible thereafter, the specimen then being forwarded to the central processing laboratory.
In the laboratory a small disc from one of the blood spots is incubated overnight in an assay dish containing spores of a strain of Bacillus subtilis and a substance which inhibits its growth, as well as a series of control discs impregnated with various concentrations of phenylalanine, which permits growth of B. subtilis in the presence of the inhibitor. One hundred test discs can be included on each assay dish. Comparison of the halo of growth of B. subtilis round the test disc with that round the control discs gives an assessment of the phenylalanine content of the test blood. The Guthrie test as used detects and estimates concentrations of phenylalanine down to about 2 mg./100 ml. of blood. A level of 6 mg./100 ml. or more is regarded as a result requiring fuller investigation.
In Scotland in 1966-7 such levels were found in 162 out of 57,000 children tested (at an age of 5 days or more)-that is, in less than 3 per 1,000.
A series of surveys were made with this test in special schools, in mental subnormality institutions, and among the newborn in Glasgow between November 1964 and November 1965. Since then the test has been used routinely for all newborn infants in Glasgow, Edinburgh, and the surrounding counties; the area covered has expanded rapidly and now includes the whole of the South-east Scotland Region (Report, 1968 (Carter and Woolf, 1961 days, to the modified Guthrie test on urine between 3 and 5 days, and to the other two tests before the age of 3 days. It appears from these comparisons (coupled with the data for Children 4, 6, and 7) that the Phenistix test was on average the latest to become positive, the modified Guthrie test on urine and the paper chromatography test next, and the Guthrie test on blood probably the earliest.
It is important also to assess what the findings with each test would have been at different fixed intervals after birth. In making this evaluation it has been assumed that any test made previous to the last negative result would also have given a negative result, and that any test made (in the absence of treatment) after the first positive result would also have given a positive result; there is ample support for and no contradiction to these assumptions in the observed findings. Such an analysis was made at ages 5, 7, and 10 days, and 2, 3, and 4 weeks, and the results are shown in Table II . At 10 days, Tables, parallel  results with the four screening tests were also obtained for another group of 21 children, who are younger siblings of known patients but who were found not to have phenylketonuria themselves. Sixteen of these children consistently gave negative results with all the tests made, but five gave sporadic positive or " trace " readings-that is, below the level accepted as indicating a need for further investigation-in one or more of the tests. One of these five children was positive to the Guthrie test on blood at the age of 4, 8, and 12 days (and had trace readings at 2, 6, and 10 days) ; one was positive to the Guthrie test on urine at 7 and 9 days; one was positive to the Guthrie test on blood at the age of 1 day and to the modified Guthrie test on urine at 7 days; one who showed tyrosyluria consistently from 5 to 19 days by the paper chromatography test on urine was positive to the Guthrie test on blood at the age of 5 days (and had trace readings at 7, 9, 11, and 13 days); and one child had trace readings in the paper chromatography test on urine consistently from 2 to 20 days. The results of all the other tests made on these five children were negative.
In the assessment of these findings it must be remembered that these children are a special group, about two-thirds of whom will be heterozygotes for the phenylketonuria gene. The frequency of occasional positive readings in screening tests for phenylketonuria may be greater in such a group than in a general population group.
Relative Merits of Four Screening Procedures
The above test findings, and experience with the four procedures in this country, permit an assessment of the relative merits of the screening procedures. This assessment is made in relation to each of the seven desiderata for a screening test listed above.
Efficiency in Detecting Phenylketonuria
It has become increasingly evident during the past few years that the efficiency of the Phenistix test in detecting phenylketonuria is inadequate for a mass screening procedure. In a substantial proportion of phenylketonuric patients-perhaps between a quarter and a half-the Phenistix test, used routinely at about 4 to 6 weeks of age, gives a negative result and the child is regarded as normal, usually until obvious brain damage has taken place. One reason for this basic defect in the test is that there may not be a sufficiently raised level of phenylpyruvic acid in the urine of a phenylketonuric child to give a positive result during the early weeks of life. Practical difficulties in performing the test satisfactorily, and in reading the result, also contribute to the inefficiency of the test.
The Working Party's comparative study of the four screening tests has shown that in patients with phenylketonuria both the paper chromatography test on urine and the Guthrie test on blood are likely to be positive by the end of the first week of life, but it has confirmed that the Phenistix test may still give a negative result several weeks later. Because it is likely that a test which gives positive results from an early date will prove more efficient in practice than one which may only become positive later, these two tests may both be judged preferable to the Phenistix test as a basis for a screening procedure. The modified Guthrie test on urine appears to occupy an intermediate position.
No instance of a patient who was completely missed by any of these other three tests in routine screening practice in Britain has yet been reported. However, only the Guthrie test on blood has been used for long enough, and on a large enough scale, in an area with a high prevalence of phenylketonuria for it to be evident that its efficiency at an age of about 6 days, even if it eventually proves to be less than 100%, must be substantially greater than that of the Phenistix test.
Coverage of all Newborn Infants
Though numerical information is not available for two of the four screening procedures, it appears that a very high coverage of newborn infants can be attained with all of them, whether the method of collecting specimens is through hospitals and midwives or through mothers and health visitors. Some difficulties were experienced in the Liverpool area, however, during periods when there was a shortage of health visitors. In terms of coverage there is an inherent practical advantage in a screening procedure which is planned to take place at an early age, in that effective arrangements may (and should) be built into the procedure to ensure that infants who miss the screening test at the planned time are tested later, but before it is too late to prevent brain damage in those children with phenylketonuria.
Repeat Testing-Simplicity and Economy
There does not seem to be any advantage in a procedure involving repeat tests which would be commensurate with the additional cost and effort. Because some patients repeatedly fail to give a positive result, patients missed by one Phenistix test may also be missed by a second (Woolf, Ounsted, Lee, Humphrey, Cheshire, and Steed, 1961; Mabry, Nelson, and Horner, 1962) . Again, though it has been estimated (Guthrie, personal communication) that a single Guthrie test on blood at an age of about 3 days would miss at least 11 % of patients, it would appear from the steep rise in the serum phenylalanine level in children with phenylketonuria during the first few days of life (Hsia, 1967) (Berry et al., 1964) . In the comparative investigation the Guthrie test on blood was quite reliable from the age of 5 days, and it is recommended (Report, 1968) that the test should not be performed before the age of 6 days-; below the age of 4 days, as has been found in the United States, there is a risk that a phenylketonuric infant might be missed. (Hill, Summer, Pender, and Roszel, 1965) ; and (b) chromatography of amino-acids in blood (1) dried on filter paper (Efron, Young, Moser, and MacCready, 1964) , (2) dried on filter paper or in heparinized capillary tubes (Scriver, Davies, and Cullen, 1964) , and (3) in heparinized capillary tubes (Berry, 1962; Mellon and Stiven, 1966) .
After the Working Party's comparison of the four screening tests had begun a pilot study of one of the above screening procedures was started in the Manchester area by Dr. G. M. Komrower, based on chromatography of a blood specimen (Scriver et al., 1964 
Discussion
From the above considerations it is clear that, despite its simplicity of performance, the Phenistix test can no longer be regarded as a satisfactory basis for a screening procedure for phenylketonuria. The overriding reason is that the test passes as normal a substantial proportion of patients with the disease when it is used routinely between 4 and 6 weeks of age, and at an earlier age it would be even less reliable.
Of the other three tests considered, all of which have been used in routine screening procedures in this country, though for a relatively short period of time, the modified Guthrie test on urine would appear to have no special advantages over the other two, and may be rather less efficient in detecting phenylketonuria at an early age. Because it is a test on urine the results are likely to be more variable than are those of the Guthrie test on blood, and the laboratory procedure is rather more complex than that for the paper chromatography test.
Both the paper chromatography test on urine and the Guthrie test on blood are substantially more reliable than is the Phenistix test, and both involve setting up comprehensive field arrangements and streamlined central laboratory facilities. The Guthrie test on blood appears to be highly efficient in practice, but because smaller numbers of subjects have so far been tested there is less information on the efficiency of the urine chromatography test; both tests probably have very occasional lapses.
The Guthrie test on blood therefore has to be preferred, because there is more assurance of its high efficiency as a result of its wider use. It also has the advantage of being a direct test for the presence of excess phenylalanine in the blood. Moreover, it has been shown to be practicable io collect specimens for the Guthrie test on blood at an age of about 1 week, whereas the paper chromatography test has generally been carried out later-namely, at about 2 weeks; because it is not known how early brain damage begins to take place in a phenylketonuric child there is an advantage in detecting the disease as early as possible. It appears to be no more difficult to obtain blood specimens from all infants than to obtain urine specimens.
When there is a general change in this country away from a screening procedure based on the Phenistix test, as would now appear to be desirable, the most satisfactory screening procedure to change to would be one based on the Guthrie test on blood. It seems unlikely that a screening procedure based on this test would require any radical alteration for at least five years and possibly much longer. There may well be developments in the relevant laboratory techniques, but this should not affect the administrative machinery for collecting the specimens, because there seems little doubt that a test on blood requiring central laboratory facilities would still form the basis of any more satisfactory screening procedure that might be evolved.
The introduction of the Guthrie test on blood throughout Britain should not, however, be a deterrent to the continued use and further study of other screening tests. In particular, it would be valuable for the paper chromatography test on urine to be used in parallel with the Guthrie test on blood in certain areas, in order that more experience might be gained with this method.
At the present time the importance of screening for phenylketonuria depends largely on the value of dietary treatment. Now that the treatment has been in use for several years it should be possible to make some tentative evaluation of it, and the Medical Research Council is considering the ways in which this might best be approached.
